Autoimmune Arthritis. The Interface Between the Immune System and Joints.

Advances in Immunology

Volumn 115, Issue , 2012, Pages 45-71

  Komatsu, Noriko ^a   Takayanagi, Hiroshi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Animal model; Arthritis; Autoimmune Disease; Osteoclast; Synovial Fibroblast

Indexed keywords

CD4 ANTIGEN; COMPLEMENT COMPONENT C5A; DECTIN 1; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE DESTRUCTION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHONDROPATHY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MEDICAL RESEARCH; MESENCHYME CELL; MOLECULAR MECHANICS; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVITIS; TH17 CELL;

EID: 84861139699     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394299-9.00002-3     Document Type: Chapter

References (123)

1. Abdollahi-Roodsaz S., Joosten L.A., Roelofs M.F., Radstake T.R., Matera G., Popa C., van der Meer J.W., Netea M.G., van den Berg W.B. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007, 56:2957-2967.
2. Abdollahi-Roodsaz S., Joosten L.A., Koenders M.I., Devesa I., Roelofs M.F., Radstake T.R., Heuvelmans-Jacobs M., Akira S., Nicklin M.J., Ribeiro-Dias F., van den Berg W.B. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 2008, 118:205-216.
3. Abu-Amer Y., Erdmann J., Alexopoulou L., Kollias G., Ross F.P., Teitelbaum S.L. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 2000, 275:27307-27310.
4. Aidinis V., Plows D., Haralambous S., Armaka M., Papadopoulos P., Kanaki M.Z., Koczan D., Thiesen H.J., Kollias G. Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res. Ther. 2003, 5:R140-R157.
5. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., De Benedetti F., Poli V., Ciliberto G. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 1998, 187:461-468.
6. Atsumi T., Ishihara K., Kamimura D., Ikushima H., Ohtani T., Hirota S., Kobayashi H., Park S.J., Saeki Y., Kitamura Y., Hirano T. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 2002, 196:979-990.
7. Bartok B., Firestein G.S. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol. Rev. 2010, 233:233-255.
8. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., Ardlie K.G., Huang Q., Smith A.M., Spoerke J.M., Conn M.T., Chang M., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004, 75:330-337.
9. - responder T cells. J. Immunol. 2009, 183:8268-8279.
10. Binstadt B.A., Patel P.R., Alencar H., Nigrovic P.A., Lee D.M., Mahmood U., Weissleder R., Mathis D., Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 2006, 7:284-292.
11. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., Massarotti E.M., Remold-O'Donnell E., Farndale R.W., Ware J., Lee D.M. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
12. Brackertz D., Mitchell G.F., Mackay I.R. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 1977, 20:841-850.
13. Bromley M., Woolley D.E. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum. 1984, 27:968-975.
14. Buch M.H., Bingham S.J., Seto Y., McGonagle D., Bejarano V., White J., Emery P. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade. Arthritis Rheum. 2004, 50:725-728.
15. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 2004, 6:R335-R346.
16. Chang S.K., Noss E.H., Chen M., Gu Z., Townsend K., Grenha R., Leon L., Lee S.Y., Lee D.M., Brenner M.B. Cadherin-11 regulates fibroblast inflammation. Proc. Natl. Acad. Sci. USA 2011, 108:8402-8407.
17. H 17 cells inhibits autoimmune disease. Nat. Med. 2009, 15:766-773.
18. + T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011, 63:2504-2515.
19. Dore R.K., Cohen S.B., Lane N.E., Palmer W., Shergy W., Zhou L., Wang H., Tsuji W., Newmark R. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann. Rheum. Dis. 2010, 69:872-875.
20. Douni E., Akassoglou K., Alexopoulou L., Georgopoulos S., Haralambous S., Hill S., Kassiotis G., Kontoyiannis D., Pasparakis M., Plows D., Probert L., Kollias G. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J. Inflamm. 1995, 47:27-38.
21. Edwards J.C., Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 2001, 40:205-211.
22. Edwards J.C., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., Stevens R.M., Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 2004, 350:2572-2581.
23. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
24. Flores-Borja F., Jury E.C., Mauri C., Ehrenstein M.R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2008, 105:19396-19401.
25. Fujimoto M., Serada S., Mihara M., Uchiyama Y., Yoshida H., Koike N., Ohsugi Y., Nishikawa T., Ripley B., Kimura A., Kishimoto T., Naka T. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum. 2008, 58:3710-3719.
26. Geiler T., Kriegsmann J., Keyszer G.M., Gay R.E., Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum. 1994, 37:1664-1671.
27. Genovese M.C., Van den Bosch F., Roberson S.A., Bojin S., Biagini I.M., Ryan P., Sloan-Lancaster J. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 2010, 62:929-939.
28. Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., Goldring S.R. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000, 43:250-258.
29. Hashimoto M., Hirota K., Yoshitomi H., Maeda S., Teradaira S., Akizuki S., Prieto-Martin P., Nomura T., Sakaguchi N., Kohl J., Heyman B., Takahashi M., et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 2010, 207:1135-1143.
30. Hata H., Sakaguchi N., Yoshitomi H., Iwakura Y., Sekikawa K., Azuma Y., Kanai C., Moriizumi E., Nomura T., Nakamura T., Sakaguchi S. Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J. Clin. Invest. 2004, 114:582-588.
31. + Th cells that cause autoimmune arthritis. J. Exp. Med. 2007, 204:41-47.
32. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T., Sakaguchi N., Sakaguchi S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 2007, 204:2803-2812.
33. Hofbauer L.C., Lacey D.L., Dunstan C.R., Spelsberg T.C., Riggs B.L., Khosla S. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999, 25:255-259.
34. Horai R., Nakajima A., Habiro K., Kotani M., Nakae S., Matsuki T., Nambu A., Saijo S., Kotaki H., Sudo K., Okahara A., Tanioka H., et al. TNF-α is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J. Clin. Invest. 2004, 114:1603-1611.
35. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., Yi J., Guentert T., Tousson A., Stanus A.L., Le T.V., Lorenz R.G., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 2008, 9:166-175.
36. Hueber A.J., Asquith D.L., Miller A.M., Reilly J., Kerr S., Leipe J., Melendez A.J., McInnes I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 2010, 184:3336-3340.
37. Hueber W., Patel D.D., Dryja T., Wright A.M., Koroleva I., Bruin G., Antoni C., Draelos Z., Gold M.H., Durez P., Tak P.P., Gomez-Reino J.J., et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2010, 2:52ra72.
38. Irmler I.M., Gajda M., Brauer R. Exacerbation of antigen-induced arthritis in IFN-γ-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 2007, 179:6228-6236.
39. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T., et al. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 1990, 145:3297-3303.
40. Ito Y., Usui T., Kobayashi S., Iguchi-Hashimoto M., Ito H., Yoshitomi H., Nakamura T., Shimizu M., Kawabata D., Yukawa N., Hashimoto M., Sakaguchi N., et al. γ/δ T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 2009, 60:2294-2303.
41. Jacobs J.P., Wu H.J., Benoist C., Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc. Natl. Acad. Sci. USA 2009, 106:21789-21794.
42. Ji H., Ohmura K., Mahmood U., Lee D.M., Hofhuis F.M., Boackle S.A., Takahashi K., Holers V.M., Walport M., Gerard C., Ezekowitz A., Carroll M.C., et al. Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168.
43. Ji H., Pettit A., Ohmura K., Ortiz-Lopez A., Duchatelle V., Degott C., Gravallese E., Mathis D., Benoist C. Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J. Exp. Med. 2002, 196:77-85.
44. Joosten L.A., Helsen M.M., van de Loo F.A., van den Berg W.B. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF α, anti-IL-1α /β, and IL-1Ra. Arthritis Rheum. 1996, 39:797-809.
45. Kagari T., Doi H., Shimozato T. The importance of IL-1 β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 2002, 169:1459-1466.
46. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991, 10:4025-4031.
47. Kim N., Kadono Y., Takami M., Lee J., Lee S.H., Okada F., Kim J.H., Kobayashi T., Odgren P.R., Nakano H., Yeh W.C., Lee S.K., et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 2005, 202:589-595.
48. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 2007, 8:191-197.
49. + regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 2007, 357:1046-1052.
50. Kochi Y., Okada Y., Suzuki A., Ikari K., Terao C., Takahashi A., Yamazaki K., Hosono N., Myouzen K., Tsunoda T., Kamatani N., Furuichi T., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 2010, 42:515-519.
51. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., Capparelli C., Li J., Elliott R., McCabe S., Wong T., Campagnuolo G., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304-309.
52. Korganow A.S., Ji H., Mangialaio S., Duchatelle V., Pelanda R., Martin T., Degott C., Kikutani H., Rajewsky K., Pasquali J.L., Benoist C., Mathis D. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461.
53. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.
54. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822.
55. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., Teitelbaum S.L. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 2000, 106:1481-1488.
56. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
57. Lee A.T., Li W., Liew A., Bombardier C., Weisman M., Massarotti E.M., Kent J., Wolfe F., Begovich A.B., Gregersen P.K. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005, 6:129-133.
58. Lee D.M., Kiener H.P., Agarwal S.K., Noss E.H., Watts G.F., Chisaka O., Takeichi M., Brenner M.B. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315:1006-1010.
59. Lefevre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., Korb A., Schnaker E.M., Tarner I.H., Robbins P.D., Evans C.H., Sturz H., et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 2009, 15:1414-1420.
60. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., van den Berg W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004, 50:650-659.
61. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., Huang S., Boissier M.C., Fournier C. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997, 158:5501-5506.
62. Matmati M., Jacques P., Maelfait J., Verheugen E., Kool M., Sze M., Geboes L., Louagie E., Guire C.M., Vereecke L., Chu Y., Boon L., et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 2011, 43:908-912.
63. Matsuki T., Isoda K., Horai R., Nakajima A., Aizawa Y., Suzuki K., Ohsuzu F., Iwakura Y. Involvement of tumor necrosis factor-α in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice. Circulation 2005, 112:1323-1331.
64. Matsumoto I., Staub A., Benoist C., Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999, 286:1732-1735.
65. Matsumoto I., Maccioni M., Lee D.M., Maurice M., Simmons B., Brenner M., Mathis D., Benoist C. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 2002, 3:360-365.
66. Midwood K., Sacre S., Piccinini A.M., Inglis J., Trebaul A., Chan E., Drexler S., Sofat N., Kashiwagi M., Orend G., Brennan F., Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 2009, 15:774-780.
67. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 2009, 361:888-898.
68. Monte K., Wilson C., Shih F.F. Increased number and function of FoxP3 regulatory T cells during experimental arthritis. Arthritis Rheum. 2008, 58:3730-3741.
69. Moreland L.W., Alten R., Van den Bosch F., Appelboom T., Leon M., Emery P., Cohen S., Luggen M., Shergy W., Nuamah I., Becker J.C. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 2002, 46:1470-1479.
70. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 2003, 48:1452-1460.
71. + regulatory T cells. Arthritis Rheum. 2005, 52:2212-2221.
72. Muller-Ladner U., Kriegsmann J., Franklin B.N., Matsumoto S., Geiler T., Gay R.E., Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 1996, 149:1607-1615.
73. Murakami M., Okuyama Y., Ogura H., Asano S., Arima Y., Tsuruoka M., Harada M., Kanamoto M., Sawa Y., Iwakura Y., Takatsu K., Kamimura D., et al. Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J. Exp. Med. 2011, 208:103-114.
74. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003, 171:6173-6177.
75. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J.Q., Bonewald L.F., Kodama T., Wutz A., Wagner E.F., Penninger J.M., Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 2011, 17:1231-1234.
76. Nakken B., Munthe L.A., Konttinen Y.T., Sandberg A.K., Szekanecz Z., Alex P., Szodoray P. B-cells and their targeting in rheumatoid arthritis-Current concepts and future perspectives. Autoimmun. Rev. 2011, 11:28-34.
77. Nandakumar K.S., Backlund J., Vestberg M., Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res. Ther. 2004, 6:R544-R550.
78. Nguyen L.T., Jacobs J., Mathis D., Benoist C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 2007, 56:509-520.
79. Notley C.A., Inglis J.J., Alzabin S., McCann F.E., McNamee K.E., Williams R.O. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 2008, 205:2491-2497.
80. Ogura H., Murakami M., Okuyama Y., Tsuruoka M., Kitabayashi C., Kanamoto M., Nishihara M., Iwakura Y., Hirano T. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008, 29:628-636.
81. Perricone C., Ceccarelli F., Valesini G. An overview on the genetic of rheumatoid arthritis: A never-ending story. Autoimmun. Rev. 2011, 10:599-608.
82. Pettit A.R., Ji H., von Stechow D., Muller R., Goldring S.R., Choi Y., Benoist C., Gravallese E.M. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 2001, 159:1689-1699.
83. Pollinger B., Junt T., Metzler B., Walker U.A., Tyndall A., Allard C., Bay S., Keller R., Raulf F., Di Padova F., O'Reilly T., Horwood N.J., et al. Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J. Immunol. 2011, 186:2602-2612.
84. Probert L., Plows D., Kontogeorgos G., Kollias G. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 1995, 25:1794-1797.
85. Ranges G.E., Sriram S., Cooper S.M. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 1985, 162:1105-1110.
86. Redlich K., Hayer S., Ricci R., David J.P., Tohidast-Akrad M., Kollias G., Steiner G., Smolen J.S., Wagner E.F., Schett G. Osteoclasts are essential for TNF-α-mediated joint destruction. J. Clin. Invest. 2002, 110:1419-1427.
87. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
88. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
89. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
90. + T cells. J. Exp. Med. 2006, 203:1459-1470.
91. Schroder A.E., Greiner A., Seyfert C., Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 1996, 93:221-225.
92. Singh K., Colmegna I., He X., Weyand C.M., Goronzy J.J. Synoviocyte stimulation by the LFA-1-intercellular adhesion molecule-2-Ezrin-Akt pathway in rheumatoid arthritis. J. Immunol. 2008, 180:1971-1978.
93. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., Li Y., Kurreeman F.A., Zhernakova A., Hinks A., Guiducci C., Chen R., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 2010, 42:508-514.
94. Stuart J.M., Dixon F.J. Serum transfer of collagen-induced arthritis in mice. J. Exp. Med. 1983, 158:378-392.
95. Svensson L., Jirholt J., Holmdahl R., Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 1998, 111:521-526.
96. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 2009, 5:667-676.
97. Takayanagi H., Oda H., Yamamoto S., Kawaguchi H., Tanaka S., Nishikawa T., Koshihara Y. A new mechanism of bone destruction in rheumatoid arthritis: Synovial fibroblasts induce osteoclastogenesis. Biochem. Biophys. Res. Commun. 1997, 240:279-286.
98. Takayanagi H., Iizuka H., Juji T., Nakagawa T., Yamamoto A., Miyazaki T., Koshihara Y., Oda H., Nakamura K., Tanaka S. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000, 43:259-269.
99. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., Nakamura K., Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000, 408:600-605.
100. Takemura S., Klimiuk P.A., Braun A., Goronzy J.J., Weyand C.M. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 2001, 167:4710-4718.
101. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., Koishihara Y., Ohsugi Y., Kumaki K., Taga T., et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA 1993, 90:11924-11928.
102. Taniguchi K., Kohsaka H., Inoue N., Terada Y., Ito H., Hirokawa K., Miyasaka N. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 1999, 5:760-767.
103. Taylor B.A., Wnek C., Kotlus B.S., Roemer N., MacTaggart T., Phillips S.J. Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps. Mamm. Genome 1999, 10:335-348.
104. Taylor P.C., Peters A.M., Paleolog E., Chapman P.T., Elliott M.J., McCloskey R., Feldmann M., Maini R.N. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000, 43:38-47.
105. Terato K., Hasty K.A., Reife R.A., Cremer M.A., Kang A.H., Stuart J.M. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 1992, 148:2103-2108.
106. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 2002, 20:795-823.
107. + regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004, 50:2775-2785.
108. Vermeire K., Heremans H., Vandeputte M., Huang S., Billiau A., Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol. 1997, 158:5507-5513.
109. Wehrens E.J., Mijnheer G., Duurland C.L., Klein M., Meerding J., van Loosdregt J., de Jager W., Sawitzki B., Coffer P.J., Vastert B., Prakken B.J., van Wijk F. Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 2011, 118:3538-3548.
110. Williams R.O., Feldmann M., Maini R.N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1992, 89:9784-9788.
111. Wipke B.T., Allen P.M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 2001, 167:1601-1608.
112. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997, 186:2075-2080.
113. Wong P.K., Quinn J.M., Sims N.A., van Nieuwenhuijze A., Campbell I.K., Wicks I.P. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 2006, 54:158-168.
114. Wooley P.H., Luthra H.S., Stuart J.M., David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 1981, 154:688-700.
115. Wu H.J., Ivanov J., Darce K., Hattori T., Shima Y., Umesaki D.R., Littman C.Benoist, Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
116. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O'Brien C.A. Matrix-embedded cells control osteoclast formation. Nat. Med. 2011, 17:1235-1241.
117. Yao C., Sakata D., Esaki Y., Li Y., Matsuoka T., Kuroiwa K., Sugimoto Y., Narumiya S. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 2009, 15:633-640.
118. Yeo L., Toellner K.M., Salmon M., Filer A., Buckley C.D., Raza K., Scheel-Toellner D. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann. Rheum. Dis. 2011, 70:2022-2028.
119. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., Hirota K., Tanaka S., Nomura T., Miki I., Gordon S., Akira S., et al. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 2005, 201:949-960.
120. Zaiss M.M., Axmann R., Zwerina J., Polzer K., Guckel E., Skapenko A., Schulze-Koops H., Horwood N., Cope A., Schett G. Treg cells suppress osteoclast formation: A new link between the immune system and bone. Arthritis Rheum. 2007, 56:4104-4112.
121. Zaiss M.M., Frey B., Hess A., Zwerina J., Luther J., Nimmerjahn F., Engelke K., Kollias G., Hunig T., Schett G., David J.P. Regulatory T cells protect from local and systemic bone destruction in arthritis. J. Immunol. 2010, 184:7238-7246.
122. Zaiss M.M., Sarter K., Hess A., Engelke K., Bohm C., Nimmerjahn F., Voll R., Schett G., David J.P. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. Arthritis Rheum. 2010, 62:2328-2338.
123. Zanin-Zhorov A., Ding Y., Kumari S., Attur M., Hippen K.L., Brown M., Blazar B.R., Abramson S.B., Lafaille J.J., Dustin M.L. Protein kinase C-θ mediates negative feedback on regulatory T cell function. Science 2010, 328:372-376.